Clinical Trials in Houston

Showing 4741-4760 of 13,620 trials

Cefadroxil 500 mg Capsules Under Fasting Conditions

NCT00834275

The objective of this study is to compare the relative bioavailability of cefadroxil 500 mg capsules (manufactured by Teva Pharmaceuticals USA) with that of DURICEF® 500 mg capsules (manufactured by Bristol-Myers Squibb Company) when dosed (1 x 500 mg capsules) in normal healthy non-smoking male and female subjects under fasting conditions.

Healthy

Teva Pharmaceuticals USA26 participantsStarted Sep 2004

Houston, Texas, United States • Toronto, Ontario, Canada

RECRUITINGEARLY Phase 1< 1 mile

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

NCT03537482

This is a multi-center, single-agent, open-label, Phase I study of APG-2575. The study consists of the dose escalation stage and the dose expansion stage.

Hematologic Malignancies

Ascentage Pharma Group Inc.90 participantsStarted Aug 2018

Jacksonville, Florida, United States • Durham, North Carolina, United States • Houston, Texas, United States +2 more locations

COMPLETED< 1 mile

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

NCT02719184

The study will include 60 healthy subjects (ex-smoker without any airflow limitation), 125 COPD GOLD (global initiative for chronic obstructive lung disease) I , 125 COPD GOLD II, 125 COPD GOLD III and up to 20 patients with COPD and A1AT (Alpha1-Antitrypsin) deficiency (ZZ genotype). Soluble and imaging biomarkers will be investigated addressing different aspects of disease pathways postulated to be relevant for COPD progression.

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Boehringer Ingelheim463 participantsStarted Apr 2016

Birmingham, Alabama, United States • San Diego, California, United States • Torrance, California, United States +48 more locations

Cefadroxil 500 mg Capsules Under Fasting Conditions

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Find Trials by Condition in Houston

Study of Selected X-linked Disorders: Goltz Syndrome

Study of Selected X-Linked Disorders: Aicardi Syndrome

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

A Study of ZN-c5 in Subjects With Breast Cancer

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study of OMNI System in OAG (GEMINI)

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)